(Q44929080)

7 December 2017

title

Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening (English)

1 reference

7 December 2017

author

Olav Wendelboe Nielsen

object named as

Olav W Nielsen

series ordinal

4

0 references

Lars Køber

series ordinal

2

object named as

Lars Køber

1 reference

7 December 2017

0 references

Jan Rasmussen

1

1 reference

7 December 2017

Allan M Lund

series ordinal

3

1 reference

7 December 2017

publication date

21 August 2013

1 reference

Journal of Inherited Metabolic Disease

7 December 2017

published in

1 reference

7 December 2017

volume

37

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

223-230

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-013-9640-0

7 December 2017

exact match

0 references

cites work

Primary carnitine deficiency dilated cardiomyopathy: 28years follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine membrane transporter deficiency: a rare treatable cause of cardiomyopathy and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Primary Carnitine Deficiency Presents Atypically with Long QT Syndrome: A Case Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Disorders of carnitine transport and the carnitine cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine deficiency-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine deficiency disorders in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine: a nutritional, biosynthetic, and functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Carnitine transport: pathophysiology and metabolism of known molecular defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-013-9640-0

A formula to estimate the approximate surface area if height and weight be known. 1916.

21 January 2018

1 reference

12 December 2020

Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants

1 reference

12 December 2020

Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency

1 reference

12 December 2020

Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands

1 reference

12 December 2020

Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation

1 reference

12 December 2020

Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children

1 reference

12 December 2020

Expanded newborn screening identifies maternal primary carnitine deficiency

1 reference

12 December 2020

Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting

1 reference

12 December 2020

Dilated cardiomyopathy caused by plasma membrane carnitine transport defect

1 reference

12 December 2020

Phenotypic manifestations of the OCTN2 V295X mutation: sudden infant death and carnitine-responsive cardiomyopathy in Roma families

1 reference

12 December 2020

Cardiac manifestations in disorders of fat and carnitine metabolism in infancy

1 reference

12 December 2020

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)

1 reference

12 December 2020

Speckle-tracking echocardiography: a new technique for assessing myocardial function

1 reference

12 December 2020

Carnitine metabolism in human subjects I. Normal metabolism,

1 reference

12 December 2020

L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease

1 reference

12 December 2020

10.1007/S10545-013-9640-0

Identifiers

DOI

1 reference

7 December 2017

1 reference